Effects of resveratrol (trans-3,5,4′-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 3, 2007, Pages 916-923

  Burstein, Brett ^a,b   Maguy, Ange ^a   Clément, Robert ^a   Gosselin, Hugues ^a   Poulin, Francine ^a   Ethier, Nathalie ^b   Tardif, Jean Claude ^a   Hébert, Terence E ^b   Calderone, Angelino ^a   Nattel, Stanley ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; DOBUTAMINE; RESVERATROL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEART CONTRACTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DENSITY; SARCOPLASMIC RETICULUM; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 36349009392     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.127548     Document Type: Article

References (47)

1. Ahmed MS, Oie E, Vinge LE, Yndestad A, Oystein AG, Andersson Y, Attramadal T, and Attramadal H (2004) Connective tissue growth factor-a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 36:393-404.
2. Ahmed MS, von Lueder TG, Oie E, Kjekshus H, and Attramadal H (2005) Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs. Acta Physiol Scand 184:27-36.
3. Asselin C, Shi Y, Clement R, Tardif JC, and Des RC (2007) Higher circulating 4-hydroxynonenal-protein thioether adducts correlate with more severe diastolic dysfunction in spontaneously hypertensive rats. Redox Rep 12:68-72.
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342.
5. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
6. Belguendouz L, Fremont L, and Gozzelino MT (1998) Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol 55:811-816.
7. Blumenstein I, Keseru B, Wolter F, and Stein J (2005) The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro. Clin Cancer Res 11:5651-5656.
8. Brodde OE (1993) Beta-adrenoceptors in cardiac disease. Pharmacol Ther 60:405-430.
9. Brown L, Deighton NM, Bals S, Sohlmann W, Zerkowski HR, Michel MC, and Brodde OE (1992) Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222-232.
10. Chen MM, Lam A, Abraham JA, Schreiner GF, and Joly AH (2000) CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32:1805-1819.
11. Chen WP, Su MJ, and Hung LM (2007) In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur J Pharmacol 554:196-204.
12. Das DK and Maulik N (2006) Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 6:36-47.
13. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, and Das DK (2005) Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 42:281-289.
14. Das S, Falchi M, Bertelli A, Maulik N, and Das DK (2006) Attenuation of ischemia/ reperfusion injury in rats by the anti-inflammatory action of resveratrol. Arzneimittelforschung 56:700-706.
15. Dean RG, Balding LC, Candido R, Burns WC, Cao Z, Twigg SM, and Burrell LM (2005) Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 53:1245-1256.
16. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, and de Gaetano G (2002) Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105:2836-2844.
17. Drapeau J, El Helou V, Clement R, Bel-Hadj S, Gosselin H, Trudeau LE, Villeneuve L, and Calderone A (2005) Nestin-expressing neural stem cells identified in the scar following myocardial infarction. J Cell Physiol 204:51-62.
18. El Mowafy AM and Alkhalaf M (2003) Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24:869-873.
19. Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A, and Maulik N (2006) Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44:43-49.
20. Hale SL and Kloner RA (2001) Effects of resveratrol, a flavanoid found in red wine, on infarct size in an experimental model of ischemia/reperfusion. J Stud Alcohol 62:730-735.
21. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, and Dixon IM (1999) Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667-678.
22. Hattori R, Otani H, Maulik N, and Das DK (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol 282:H1988-H1995.
23. Huang CY, Kuo WW, Chueh PJ, Tseng CT, Chou MY, and Yang JJ (2004) Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK. Biochem Biophys Res Commun 324:424-431.
24. Hung LM, Su MJ, and Chen JK (2004) Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 36:774-781.
25. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, and Das DK (2002) Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 282:H1996-H2003.
26. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
27. Juric D, Wojciechowski P, Das DK, and Netticadan T (2007) Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol 292:H2138-H2143.
28. Kaga S, Zhan L, Matsumoto M, and Maulik N (2005) Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39:813-822.
29. Kim YK, Kim SJ, Kramer CM, Yatani A, Takagi G, Mankad S, Szigeti GP, Singh D, Bishop SP, Shannon RP, et al. (2002) Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction. J Mol Cell Cardiol 34:63-73.
30. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, et al. (2007) Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49:1120-1127.
31. Kopp P (1998) Resveratrol, a phytoestrogen found in red wine: a possible explanation for the conundrum of the "French paradox"? Eur J Endocrinol 138:619-620.
32. Lapointe N, Nguyen QT, Desjardins JF, Marcotte F, Pourdjabbar A, Moe G, Calderone A, and Rouleau JL (2003) Effects of pre-, peri-, and postmyocardial infarction treatment with omapatrilat in rats: survival, arrhythmias, ventricular function, and remodeling. Am J Physiol Heart Circ Physiol 285:H398-H405.
33. Lee JR, Zhang X, and Tenner TE Jr (1999) Evidence for spare beta-adrenoceptors in the rabbit heart. Proc West Pharmacol Soc 42:41-44.
34. Lemire I, Allen BG, Rindt H, and Hebert TE (1998) Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk. J Mol Cell Cardiol 30:1827-1839.
35. Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, et al. (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38:243-257.
36. Martin AR, Villegas I, La Casa C, and de la Lastra CA (2004) Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol 67:1399-1410.
37. Mercier I, Colombo F, Mader S, and Calderone A (2002) Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res 53:728-739.
38. Mokni M, Limam F, Elkahoui S, Amri M, and Aouani E (2007) Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys 457:1-6.
39. Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, Doi M, Murakami T, Ninomiya Y, Takigawa M, et al. (1998) Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 30:2411-2422.
40. Olson ER, Naugle JE, Zhang X, Bomser JA, and Meszaros JG (2005) Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol 288:H1131-H1138.
41. Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R, Menon VP, Otani H, and Maulik N (2007) Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42:508-516.
42. Renaud S and de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526.
43. Wang S, Wang X, Yan J, Xie X, Fan F, Zhou X, Han L, and Chen J (2007) Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. Eur J Pharmacol 567:26-35.
44. Wenzel E, Soldo T, Erbersdobler H, and Somoza V (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49:482-494.
45. Wenzel E and Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472-481.
46. Yoshida Y, Shioi T, and Izumi T (2007) Resveratrol ameliorates experimental autoimmune myocarditis. Circ J 71:397-404.
47. Zhang Y, Liu Y, Wang T, Li B, Li H, Wang Z, and Yang B (2006) Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 340:1192-1199.